SAGE logo

Sage Therapeutics (SAGE) Depreciation And Amortization

Annual D&A

$1.39 M
+$271.00 K+24.15%

December 31, 2023


Summary


Performance

SAGE Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$255.00 K
-$56.00 K-18.01%

September 30, 2024


Summary


Performance

SAGE Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$1.31 M
-$75.00 K-5.41%

September 30, 2024


Summary


Performance

SAGE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

SAGE Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.1%-18.0%-5.4%
3 y3 years-47.0%-31.8%-70.8%
5 y5 years+21.9%-63.5%-42.6%

SAGE Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-66.7%+24.1%-37.6%at low-68.7%+16.8%
5 y5-year-66.7%+24.1%-90.1%at low-72.5%+16.8%
alltimeall time-66.7%+3065.9%-90.1%+2218.2%-72.5%>+9999.0%

Sage Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$255.00 K(-18.0%)
$1.31 M(-5.4%)
Jun 2024
-
$311.00 K(-7.4%)
$1.39 M(-1.4%)
Mar 2024
-
$336.00 K(-17.8%)
$1.41 M(+0.9%)
Dec 2023
$1.39 M(+24.2%)
$409.00 K(+23.9%)
$1.39 M(+9.3%)
Sep 2023
-
$330.00 K(-0.3%)
$1.27 M(+4.3%)
Jun 2023
-
$331.00 K(+2.5%)
$1.22 M(+4.4%)
Mar 2023
-
$323.00 K(+11.4%)
$1.17 M(+4.3%)
Dec 2022
$1.12 M(-73.2%)
$290.00 K(+4.3%)
$1.12 M(-3.7%)
Sep 2022
-
$278.00 K(-0.4%)
$1.17 M(-7.6%)
Jun 2022
-
$279.00 K(+1.5%)
$1.26 M(-32.7%)
Mar 2022
-
$275.00 K(-17.4%)
$1.88 M(-55.2%)
Dec 2021
$4.18 M(+59.0%)
$333.00 K(-11.0%)
$4.18 M(-7.0%)
Sep 2021
-
$374.00 K(-58.1%)
$4.50 M(-5.8%)
Jun 2021
-
$893.00 K(-65.4%)
$4.77 M(+5.1%)
Mar 2021
-
$2.58 M(+297.8%)
$4.54 M(+72.7%)
Dec 2020
$2.63 M(+15.2%)
$649.00 K(-0.2%)
$2.63 M(-0.6%)
Sep 2020
-
$650.00 K(-1.8%)
$2.65 M(-1.8%)
Jun 2020
-
$662.00 K(-1.0%)
$2.69 M(+6.2%)
Mar 2020
-
$669.00 K(+0.6%)
$2.54 M(+11.1%)
Dec 2019
$2.28 M(+99.7%)
$665.00 K(-4.7%)
$2.28 M(+15.2%)
Sep 2019
-
$698.00 K(+38.2%)
$1.98 M(+26.2%)
Jun 2019
-
$505.00 K(+21.7%)
$1.57 M(+19.8%)
Mar 2019
-
$415.00 K(+14.3%)
$1.31 M(+14.7%)
Dec 2018
$1.14 M
$363.00 K(+26.5%)
$1.14 M(+24.9%)
DateAnnualQuarterlyTTM
Sep 2018
-
$287.00 K(+16.7%)
$915.00 K(+19.8%)
Jun 2018
-
$246.00 K(-0.4%)
$764.00 K(+17.9%)
Mar 2018
-
$247.00 K(+83.0%)
$648.00 K(+22.0%)
Dec 2017
$531.00 K(+89.0%)
$135.00 K(-0.7%)
$531.00 K(+11.1%)
Sep 2017
-
$136.00 K(+4.6%)
$478.00 K(+12.5%)
Jun 2017
-
$130.00 K(0.0%)
$425.00 K(+14.9%)
Mar 2017
-
$130.00 K(+58.5%)
$370.00 K(+31.7%)
Dec 2016
$281.00 K(+144.3%)
$82.00 K(-1.2%)
$281.00 K(+21.6%)
Sep 2016
-
$83.00 K(+10.7%)
$231.00 K(+30.5%)
Jun 2016
-
$75.00 K(+82.9%)
$177.00 K(+32.1%)
Mar 2016
-
$41.00 K(+28.1%)
$134.00 K(+16.5%)
Dec 2015
$115.00 K(+125.5%)
$32.00 K(+10.3%)
$115.00 K(+16.2%)
Sep 2015
-
$29.00 K(-9.4%)
$99.00 K(+19.3%)
Jun 2015
-
$32.00 K(+45.5%)
$83.00 K(+33.9%)
Mar 2015
-
$22.00 K(+37.5%)
$62.00 K(+21.6%)
Dec 2014
$51.00 K(+8.5%)
$16.00 K(+23.1%)
$51.00 K(+6.3%)
Sep 2014
-
$13.00 K(+18.2%)
$48.00 K(+4.3%)
Jun 2014
-
$11.00 K(0.0%)
$46.00 K(-2.1%)
Mar 2014
-
$11.00 K(-15.4%)
$47.00 K(0.0%)
Dec 2013
$47.00 K(+6.8%)
$13.00 K(+18.2%)
$47.00 K(+38.2%)
Sep 2013
-
$11.00 K(-8.3%)
$34.00 K(+47.8%)
Jun 2013
-
$12.00 K(+9.1%)
$23.00 K(+109.1%)
Mar 2013
-
$11.00 K
$11.00 K
Dec 2012
$44.00 K
-
-

FAQ

  • What is Sage Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Sage Therapeutics?
  • What is Sage Therapeutics annual D&A year-on-year change?
  • What is Sage Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Sage Therapeutics?
  • What is Sage Therapeutics quarterly D&A year-on-year change?
  • What is Sage Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Sage Therapeutics?
  • What is Sage Therapeutics TTM D&A year-on-year change?

What is Sage Therapeutics annual depreciation & amortization?

The current annual D&A of SAGE is $1.39 M

What is the all time high annual D&A for Sage Therapeutics?

Sage Therapeutics all-time high annual depreciation & amortization is $4.18 M

What is Sage Therapeutics annual D&A year-on-year change?

Over the past year, SAGE annual depreciation & amortization has changed by +$271.00 K (+24.15%)

What is Sage Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of SAGE is $255.00 K

What is the all time high quarterly D&A for Sage Therapeutics?

Sage Therapeutics all-time high quarterly depreciation & amortization is $2.58 M

What is Sage Therapeutics quarterly D&A year-on-year change?

Over the past year, SAGE quarterly depreciation & amortization has changed by -$56.00 K (-18.01%)

What is Sage Therapeutics TTM depreciation & amortization?

The current TTM D&A of SAGE is $1.31 M

What is the all time high TTM D&A for Sage Therapeutics?

Sage Therapeutics all-time high TTM depreciation & amortization is $4.77 M

What is Sage Therapeutics TTM D&A year-on-year change?

Over the past year, SAGE TTM depreciation & amortization has changed by -$75.00 K (-5.41%)